There ar two firms involved in this merger; Grifols and Talecris. In this merger, Grifols proposes to withdraw Talecris. Lets take a look at each firm. According to Grifols (2011), they are a global health care company which produces life-saving protein therapies for patients and tools to the healthcare industry. The national Trade burster describes Grifols a manufacturer of plasma-derived drugs. Grifol s is headquartered in Barcelona, Spain with ! consummation facilities in both Barcelona and Los Angeles with centralize on developing and manufacturing human blood plasma-derived products. According to BusinessWeek (2011) Grifols 2010 annual revenues were â¬990.7M or $1.3 Billion. These revenues exceeded those of the previous year. direct we will turn our way to Talecris. The Federal Trade Commission describes Talecris as a pencil lead manufacturer in the plasma-derived drug...If you motive to get a all-encompassing essay, order it on our website: OrderEssay.net
If you want to get a full information about our service, visit our page: write my essay
No comments:
Post a Comment